RENAL FUNCTION IN PATIENTS WITH NON-DIALYSIS KIDNEY DISEASE TREATED WITH FERRIC CARBOXYMALTOSE

被引：0
|
作者：
Roldao, Marisa [1 ]
Duarte, Rui [1 ]
Escoli, Rachele [1 ]
Goncalves, Hernani [1 ]
Lobos, Ana Vila [1 ]
机构：
[1] Ctr Hosp Medio Tejo, Nephrol, Torres Novas, Portugal
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO526
引用
收藏
页码：I381 / I381
页数：1
相关论文
共 50 条
  • [1] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Iain C. Macdougall
    Andreas H. Bock
    Fernando Carrera
    Kai-Uwe Eckardt
    Carlo Gaillard
    David Van Wyck
    Yvonne Meier
    Sylvain Larroque
    Simon D. Roger
    BMC Nephrology, 18
  • [2] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Meier, Yvonne
    Larroque, Sylvain
    Roger, Simon D.
    BMC NEPHROLOGY, 2017, 18
  • [3] Efficiency of ferric carboxymaltose in non-dialysis CKD patients and its impact on kidney function: a prospective observational study
    Roldao, Marisa
    Escoli, Rachele
    Goncalves, Hernani
    Lobos, Ana Vila
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (04) : 953 - 959
  • [4] Efficiency of ferric carboxymaltose in non-dialysis CKD patients and its impact on kidney function: a prospective observational study
    Marisa Roldão
    Rachele Escoli
    Hernâni Gonçalves
    Ana Vila Lobos
    International Urology and Nephrology, 2023, 55 : 953 - 959
  • [5] EFFICIENCY OF FERRIC CARBOXYMALTOSE IN NON-DIALYSIS CKD PATIENTS AND ITS IMPACT ON KIDNEY FUNCTION: A PROSPECTIVE OBSERVATIONAL STUDY
    Roldao, Marisa
    Escoli, Rachele
    Goncalves, Hern Ani
    Lopes, Karina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 334 - 334
  • [6] ACUTE IMPACT OF A SINGLE HIGH DOSE OF FERRIC CARBOXYMALTOSE ON ENDOTHELIAL FUNCTION IN CKD NON-DIALYSIS PATIENTS
    Mehedinti, Ana-Maria
    Iosif, Liviu
    Stoian, Irina
    Andreiana, Iuliana
    Capusa, Cristina-Stela
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 336 - 336
  • [7] ECONOMICS OF INTRAVENOUS FERRIC CARBOXYMALTOSE FOR TREATMENT OF IRON DEFICIENT ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE: A PILOT STUDY IN ITALY
    Minutolo, Roberto
    Liberti, Maria Elena
    Berto, Patrizia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [8] Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney Disease
    Mima, Akira
    IN VIVO, 2023, 37 (02): : 825 - 829
  • [9] SERUM APELIN AND RENAL PROGNOSIS IN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
    Kani, Nao
    Hirata, Michinori
    Makino, Shuzo
    Naka, Tomoya
    Okamoto, Kazuhiro
    Miyakawa, Hiromitsu
    Uwatoko, Ryuta
    Bessho, Saki
    Hashimoto, Nobuhiro
    Iio, Rei
    Ueda, Yoshiyasu
    Hayashi, Terumasa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1177 - I1177
  • [10] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON HEMATINIC AND RENAL FUNCTION VARIABLES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I379 - I380
12345